Molecular genetics of malignant insulinoma

Anticancer Research

Volumn 16, Issue 4 A, 1996, Pages 1707-1717

  Pavelic, Kresimir ^a,e   Hrascan, Reno ^a   Kapitanovic, Sanja ^a   Vranes, Zoran ^b   Cabrijan, Tomislav ^b   Spaventi, Sime ^a   Korsic, Mirko ^c   Krizanac, Simun ^c   Li, Ya Qin ^d   Stambrook, Peter ^d   Gluckman, Jack L ^d   Pavelic, Zlatko P ^d  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^c KBC Zagreb   (Croatia)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Insulinoma; Oncogenes; Pancreatic tumor; Point mutations

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; INSULIN; PROTEIN P53; TRANSFORMING GROWTH FACTOR ALPHA;

ADULT; AGED; ALLELE; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; DNA HYBRIDIZATION; GENE ACTIVATION; HUMAN; HUMAN TISSUE; INSULINOMA; MOLECULAR GENETICS; ONCOGENE; ONCOGENE C FOS; ONCOGENE C JUN; ONCOGENE C MYC; ONCOGENE K RAS; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL HYPERPLASIA; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TUMOR SUPPRESSOR GENE;

ADULT; AGED; BASE SEQUENCE; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; EXONS; FEMALE; GENE EXPRESSION; GENES, MYC; GENES, P53; GENES, RAS; GROWTH SUBSTANCES; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; INSULINOMA; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MONOMERIC GTP-BINDING PROTEINS; NUCLEOSIDE-DIPHOSPHATE KINASE; PANCREATIC DISEASES; PANCREATIC NEOPLASMS; POINT MUTATION; POLYMERASE CHAIN REACTION; PROTO-ONCOGENES; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 9444297268     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Lynch HT: Genetics and pancreatic cancer. Arch Surg 129: 266-268, 1994.
2. Pellegata NS, Sessa F. Renault B, Bonato M, Leone BE, Solcia E, and Ranzani GN: K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. Cancer Res 54: 1556-1560, 1994.
3. Sandgren EP, Luetteke NC, Palmiter RD, Brinster RL, and Lee DC: Overexpression of TGFα in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, anc carcinoma of the breast. Cell 61: 1121-1135, 1990.
4. Quaife CJ, Pinkert CA, Ornitz DM, Palmiter RD, and Brinster RL: Pancreatic neoplasia induced by ras expression in acinar cells or transgenic mice. Cell 48: 1023-1034, 1987.
5. Almoguera C,Shibata D, Forrester K, Martin J, Arnheim N, and Perucho M: Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53: 549-554, 1988.
6. Fraker DL, and Norton JA: The role of surgery in the management of islet cell tumors. Gastrointest Endocrinol 18: 805-830, 1989.
7. Service FJ, McMahon MM, O'Brien PC, and Ballard DJ: Functioning insulinoma-incidence, recurrence and long term survival of patients: a 60 year study. Mayo Clinic Proc 66: 711-719, 1991.
8. Carty SE, Jensen RT, and Norton JA: Prospective study of aggressive resection of metastatic pancreatic endocrine tumors. Surgery 112: 1024-1032, 1992.
9. Pavelic K, Pavelic ZP, Denton D, Raising J, Khalily M, and Preisler HD: Immunohistochemical detection of C-MYC oncoprotein in paraffin embedded tissue. J Exp Pathol 5: 143-153, 1990.
10. Pavelic K, Pavelic ZP, and Priesler HD: C-MYC detection in bone marrow biopsies. Leukemia Res 15: 1075-1078, 1991.
11. Pavelic K, Banjac Z, Pavelic J, and Spaventi S: Evidence for a role of EGF receptor in the progression of human lung carcinoma. Anticancer Res 13: 1133-1138, 1993.
12. Poljak LJ, Pecina N, Dzubur A, Uzarevic B, Vitale B and Pavelic, K: Modulation of p62c-myc expression in a single case of non-T acute lymphoblastic leukemia (ALL) assessed bu image analyzer. Tumordiagn. Ther 14: 158-162, 1993.
13. Gall K, Pavelic J, Jadro-Santel D, Poljak M, and Pavelic K: DNA amplification by polymerase chain reaction from brain tissue embedded in paraffin. Int. J Exp Path 74: 333-337, 1993.
14. Hruban RH, van Mansfeld ADM, Offerhaus GJA, van Weering DMJ, Allison DC, Goodman SN, Kensler TW, Bose KK, Cameron JL, and Bos JL: K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol 143: 545-554, 1993.
15. Verlaan-de Vries M, Bofgaard ME, van den Elst H, van Boom JH, van der Eb AJ, and Bos JL: A dot-blot screening procedure for mutated ras oncogenes using synthetic oligodeoxynucleotides. Gene 50: 313-320, 1986.
16. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
17. Laemmly VK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
18. Spaventi R, Kamenjicki E, Pecina N, Grazio S, Grazio S, Pavelic J, Kusic B, Cvrtila D, Danilovic Z, Spaventi S, Pavelic K, Gluckman J, and Pavelic ZP: Immunohistochemical detection of TGF-α, EGF-R, c-erbB-2, c-H-ras, c-myc, estrogen and progesterone in benign and malignant human breast lesions: A concomitant expression? In Vivo 8: 183-190, 1994.
19. Spaventi R, Pavelic K, Pavelic ZP, and Gluckman JL: The concimitant expression of oncogeńes and growth factors in human breast cancer. Eur J Cancer 30A: 723-724, 1994.
20. Forrester K, Almoguera C, Han K, Grizzle WE, and Perucho M: Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 327: 298-303, 1987.
21. Farr CJ, Salki RK, Erlich HA, McCormik F, and Marshall CJ: Analysis of ras gene mutations in acute myeloid leukemia by polymerase chain reaction and oligonucleotide probes. Proc Natl Acad Sci USA 85: 1629-1633, 1988.
22. Mariyama M, Kishi K, Nakamura K, Obata H, and Nishimura S: Frequency and types of point mutation at the 12th codon of the c-K-ras gene found in pancreatic cancers from Japanese patients. Jpn J Cancer Res 80: 622-626, 1989.
23. Levi S, Urbano-Ispizna A, Gill R, Thomas DM, Gilbertson TJ, Foster C, Marshall CJ: Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res 51: 3497-3502, 1991.
24. Tada M, Omata M, Kawai S, Saisho H, Ohto M, Saiki RK, and Sninsky JJ: Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Cancer Res 53: 2472-2474, 1993.
25. Grunewals K, Lyons J, Frolich A, Feichtinger H, Weger RA, Schwab G, Jannsen JWG, and Bartram CL: High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas. Int J Cancer 43: 1037-1041, 1989.
26. Barbacid M: ras genes. Annu Rev Biochem 56: 779-827, 1987.
27. McGrath T, Capon DJ, Smith DH, Chen EY, Seeburg PH, Goeddel DV, and Levinson AD: Structure and organization of the human Kiras protooncogene and a realted processed pseudogene. Nature 304: 501-506, 1983.
28. Hirai H, Okabe T, Anraku Y, Fujisawa M, Urabe A, and Takaku F: Activation of the c-Kras oncogene in a human pancreas carcinoma. Bioch Biophys Res Comm 127: 168-174, 1985.
29. Cales C, Hancock JF, Marshall CJ, and Hall A: The cytoplasmic protein GAP is implicated as the target for regulation by the ras gene product. Nature 332: 548-551, 1988.
30. Poston GJ, Gillespie J, and Guillon PJ: Biology of pancreatic cancer. Gut 32: 800-812, 1991.
31. Korc M: Regulation of pancreatic cancer cell proliferation by an autocrine cycle conpled to the epidermal growth factor receptor. Pancreas 4: 262-263, 1989.
32. Quaife CJ, Pinkert CA, Ornitz DM, Palmiter RD, and Brinster RL: Pancreatic neoplasia induced by ras expression in acinar cells or transgenic mice. Cell 48: 1023-1034, 1987.
33. Sandgren EP, Quaife CJ, Paulovich AG, Palmiter RD, and Brinster RL: Pancreatic tumor pathogenesis reflects the causative genetic lesion. Proc Natl Acad Sci USA 88: 93-97,1991.